These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23361589)

  • 21. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.
    Gasparini G; Meo S; Comella G; Stani SC; Mariani L; Gamucci T; Avallone A; Lo Vullo S; Mansueto G; Bonginelli P; Gattuso D; Gion M
    Cancer J; 2005; 11(3):209-16. PubMed ID: 16053664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel strategies for the treatment of lung cancer: modulation of eicosanoids.
    Backlund MG; Amann JM; Johnson DH
    J Clin Oncol; 2008 Feb; 26(6):825-7. PubMed ID: 18281650
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
    Lee R; Choi YJ; Jeong MS; Park YI; Motoyama K; Kim MW; Kwon SH; Choi JH
    Bioconjug Chem; 2020 Mar; 31(3):923-932. PubMed ID: 32027493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.
    Groen HJ; Sietsma H; Vincent A; Hochstenbag MM; van Putten JW; van den Berg A; Dalesio O; Biesma B; Smit HJ; Termeer A; Hiltermann TJ; van den Borne BE; Schramel FM
    J Clin Oncol; 2011 Nov; 29(32):4320-6. PubMed ID: 21990410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling.
    Kumar BN; Rajput S; Dey KK; Parekh A; Das S; Mazumdar A; Mandal M
    BMC Cancer; 2013 Jun; 13():273. PubMed ID: 23731702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera.
    Vartak R; Saraswat A; Yang Y; Chen ZS; Patel K
    Pharm Res; 2022 Nov; 39(11):2745-2759. PubMed ID: 35146591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
    Li M; Pei J; Ma Z; Fu J; Chen F; Du S
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition.
    Jiang Y; Yang N; Zhang H; Sun B; Hou C; Ji C; Zheng J; Liu Y; Zuo P
    J Control Release; 2016 Jan; 221():26-36. PubMed ID: 26643616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity.
    Davis JL; Yi NY; Salmon JH; Charlton AN; Colitz CM; Gilger BC
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):359-68. PubMed ID: 22372691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
    Lu Z; Wientjes TS; Au JL
    Pharm Res; 2005 Jul; 22(7):1069-78. PubMed ID: 16028007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.
    Altorki NK; Port JL; Zhang F; Golijanin D; Thaler HT; Duffield-Lillico AJ; Subbaramaiah K; Dannenberg AJ
    Clin Cancer Res; 2005 Jun; 11(11):4191-7. PubMed ID: 15930356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA.
    Taratula O; Kuzmov A; Shah M; Garbuzenko OB; Minko T
    J Control Release; 2013 Nov; 171(3):349-57. PubMed ID: 23648833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of cetuximab combined with celecoxib on apoptosis and KDR and AQP1 expression in lung cancer].
    Xia H; Ye J; Bai H; Wang C
    Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):625-31. PubMed ID: 24345486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.
    Yin H; Guo R; Xu Y; Zheng Y; Hou Z; Dai X; Zhang Z; Zheng D; Xu H
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):147-53. PubMed ID: 22126905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.